How to access Ebglyss from Oman, the named-patient import pathway, 2026
By Reserve Meds · Clinical & regulatory team · Last reviewed 2026-04-23
A Oman adult or adolescent with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical therapies, or who has not responded adequately to a previous systemic therapy or biologic, may receive a prescription for Ebglyss (lebrikizumab) from their treating dermatologist. Ebglyss is FDA-approved, developed by Eli Lilly, and is a high-affinity monoclonal antibody that binds soluble IL-13 and blocks its assembly of the IL-13Ra1 / IL-4Ra signalling heterodimer. In Oman, Ebglyss's local registration status is recent and varies; it may not be broadly available for every patient who clinically qualifies, which is why your dermatologist may be navigating a named-patient import pathway with you.
This guide explains the legal pathway, what your dermatologist needs to provide, typical timelines, and where Reserve Meds fits in.
Ask about Ebglyss in Oman
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
The clinical situation
Ebglyss is administered subcutaneously. The labelled regimen for moderate-to-severe atopic dermatitis includes an initial loading phase followed by every-two-weeks maintenance through week 16, and a step-down to every-four-weeks maintenance for patients who achieve clear or almost-clear skin at week 16. Eligibility is a clinical decision by your treating dermatologist based on disease severity, prior therapies, and response pattern. Ebglyss's mechanism, blocking soluble IL-13 specifically, is distinct from dupilumab's IL-4Ra blockade and from tralokinumab's different IL-13 binding profile.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Is Ebglyss legally importable into Oman?
Yes, through the Directorate General of Pharmaceutical Affairs and Drug Control (DGPADC) named-patient import framework.
The named-patient mechanism allows an Oman-licensed physician to request import of a medicine not locally registered or not locally available for a specific patient when: (a) the medicine is approved by a recognised reference authority (FDA qualifies), (b) no locally available alternative is clinically equivalent for this patient, (c) the physician takes clinical responsibility, and (d) the importing party documents chain of custody. DGPADC reviews each application.
How the pathway works, step by step
- Consultation with your treating dermatologist. Clinical rationale documented, including severity assessment, prior therapies, and Ebglyss as the indicated therapy.
- Import authorisation application. Your dermatologist or the importing pharmacy files the DGPADC named-patient documentation including clinical rationale, patient identification (de-identified where possible), product details, and chain-of-custody plan.
- US-side sourcing. Reserve Meds coordinates with our US-licensed pharmaceutical wholesale partner under DSCSA chain-of-custody.
- Cold-chain shipment. Temperature-controlled transport with documented chain of custody.
- Arrival and administration. Subcutaneous administration per your dermatologist's protocol; most patients or caregivers self-inject at home after training.
- Ongoing coordination. Reserve Meds supports re-supply cadence aligned to the loading, every-two-weeks, or every-four-weeks maintenance dosing.
What documentation your physician needs
Your dermatologist will typically need to provide:
- Clinical rationale letter confirming diagnosis, severity, prior therapies, and Ebglyss as the indicated therapy
- Verification of their Oman medical licence (SCFHS / MOH)
- Patient identifier (anonymised reference where possible)
- Prescription with specified loading and maintenance dose
- Planned administration setting (home-injection or clinic)
Reserve Meds provides a physician documentation kit that bundles the templates DGPADC reviewers expect.
Costs and timing
Medicine price: quote on request. You get a written quote for your case before you commit. Shipment, cold-chain logistics, and coordination add incremental cost; Reserve Meds issues a transparent quote at the start of intake.
We give you a written timeline estimate for your case before you commit. Re-supply is generally faster once the pathway is established.
If your clinical situation is time-sensitive, tell us at intake. We triage accordingly.
A culturally-aware note: atopic dermatitis in Oman adults and adolescents often has a significant quality-of-life burden during pilgrimage, fasting, and community events; your dermatologist and the Reserve Meds case lead will work around clinic scheduling and travel to minimise disruption.
Reserve Meds's role
Reserve Meds is a US-based digital health company that coordinates access to cross-border specialty medicine. For Ebglyss specifically, we provide:
- Sourcing. Through our US-licensed pharmaceutical wholesale partner, operating under DSCSA chain-of-custody.
- Documentation. Regulatory documentation package for your physician and for DGPADC review.
- Logistics. Cold-chain and temperature-monitored shipment coordination.
- Dedicated case lead. A named point of contact throughout the coordination.
What we do not do: We are not the prescriber. We do not practice medicine. We are not the dispensing pharmacy. All clinical decisions remain with your treating dermatologist. Each case is scoped and prioritised individually.
Frequently asked
Is this legal? Yes, when executed through the DGPADC named-patient framework. See our trust and compliance page.
How does Ebglyss compare with dupilumab and tralokinumab? All three work in the type-2 inflammation axis; Ebglyss and tralokinumab are IL-13-specific (with different binding profiles), and dupilumab blocks the IL-4 receptor alpha affecting both IL-4 and IL-13 signalling. Your dermatologist decides which option fits your history.
Can an adolescent receive Ebglyss? Ebglyss is labelled down to the adolescent age bands in the FDA label. Your dermatologist determines suitability.
Can I self-inject at home? After training by your clinical team, most patients or caregivers self-inject at home using the pre-filled presentation.
What about side effects? Common effects include conjunctivitis, injection-site reactions, and herpes zoster in trial populations; your dermatologist manages monitoring and any adverse events.
Will MoH or insurance cover any of this? Cash-pay is the default for named-patient imports. Some Oman private insurers reimburse on case-by-case approval; we supply documentation for submission.
Next step
Composite case examples. This content is for general information and does not constitute medical advice.
Reviewed by the Reserve Meds clinical operations team. Last reviewed: 2026-04-23.
Frequently asked questions
How can I get Ebglyss in Oman if it is not approved or available there?
Reserve Meds coordinates US-sourced Ebglyss for patients in Oman through a legal named-patient pathway, working with your treating doctor. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for Oman and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Ebglyss in Oman through a named-patient import?
Often, yes. Named-patient access (sometimes called personal import) is the legal route we use for FDA-approved medicines such as Ebglyss. It is different from compassionate use, which covers investigational medicines through the manufacturer's own program; we do not supply investigational medicines. Eligibility and paperwork depend on the regulator in Oman, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Ebglyss in Oman through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Ebglyss to a patient in Oman?
Medicines are supplied through a US-licensed pharmaceutical wholesale partner, and Reserve Meds coordinates delivery of Ebglyss to your treating physician or hospital pharmacy in Oman, with appropriate handling for the product.
How long does it take, and what does Ebglyss in Oman cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Ebglyss in Oman?
Submit a 60-second intake through the Reserve Meds patient portal, or message our team on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.